515 related articles for article (PubMed ID: 22993391)
1. In vivo roles of factor XII.
Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
[TBL] [Abstract][Full Text] [Related]
2. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
3. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
[TBL] [Abstract][Full Text] [Related]
4. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
Renné T; Nieswandt B; Gailani D
Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
[TBL] [Abstract][Full Text] [Related]
5. Factor XII: a novel target for safe prevention of thrombosis and inflammation.
Kenne E; Nickel KF; Long AT; Fuchs TA; Stavrou EX; Stahl FR; Renné T
J Intern Med; 2015 Dec; 278(6):571-85. PubMed ID: 26373901
[TBL] [Abstract][Full Text] [Related]
6. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
7. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.
Stavrou E; Schmaier AH
Thromb Res; 2010 Mar; 125(3):210-5. PubMed ID: 20022081
[TBL] [Abstract][Full Text] [Related]
8. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
11. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
12. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
[TBL] [Abstract][Full Text] [Related]
13. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
[TBL] [Abstract][Full Text] [Related]
14. Contact system revisited: an interface between inflammation, coagulation, and innate immunity.
Long AT; Kenne E; Jung R; Fuchs TA; Renné T
J Thromb Haemost; 2016 Mar; 14(3):427-37. PubMed ID: 26707513
[TBL] [Abstract][Full Text] [Related]
15. In vivo activation and functions of the protease factor XII.
Björkqvist J; Nickel KF; Stavrou E; Renné T
Thromb Haemost; 2014 Nov; 112(5):868-75. PubMed ID: 25187064
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
[TBL] [Abstract][Full Text] [Related]
17. An update on factor XII-driven vascular inflammation.
Mailer RK; Rangaswamy C; Konrath S; Emsley J; Renné T
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119166. PubMed ID: 34699874
[TBL] [Abstract][Full Text] [Related]
18. Factor XII in coagulation, inflammation and beyond.
Didiasova M; Wujak L; Schaefer L; Wygrecka M
Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
[TBL] [Abstract][Full Text] [Related]
19. Roles of Factor XII in Innate Immunity.
Renné T; Stavrou EX
Front Immunol; 2019; 10():2011. PubMed ID: 31507606
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
